IL117157A - Preparation of factor ix form biological sources - Google Patents

Preparation of factor ix form biological sources

Info

Publication number
IL117157A
IL117157A IL11715796A IL11715796A IL117157A IL 117157 A IL117157 A IL 117157A IL 11715796 A IL11715796 A IL 11715796A IL 11715796 A IL11715796 A IL 11715796A IL 117157 A IL117157 A IL 117157A
Authority
IL
Israel
Prior art keywords
pct
factor
preparation
biological sources
form biological
Prior art date
Application number
IL11715796A
Other languages
English (en)
Other versions
IL117157A0 (en
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of IL117157A0 publication Critical patent/IL117157A0/xx
Publication of IL117157A publication Critical patent/IL117157A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
IL11715796A 1995-02-25 1996-02-16 Preparation of factor ix form biological sources IL117157A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19506633A DE19506633A1 (de) 1995-02-25 1995-02-25 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen

Publications (2)

Publication Number Publication Date
IL117157A0 IL117157A0 (en) 1996-06-18
IL117157A true IL117157A (en) 1999-12-22

Family

ID=7755037

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11715796A IL117157A (en) 1995-02-25 1996-02-16 Preparation of factor ix form biological sources

Country Status (20)

Country Link
US (1) US5919909A (de)
EP (1) EP0811058B1 (de)
JP (1) JPH11500910A (de)
KR (1) KR100436857B1 (de)
CN (1) CN1105779C (de)
AT (1) ATE194167T1 (de)
AU (1) AU697217B2 (de)
CA (1) CA2213577C (de)
DE (2) DE19506633A1 (de)
DK (1) DK0811058T3 (de)
EA (1) EA000222B1 (de)
ES (1) ES2147365T3 (de)
FI (1) FI119377B (de)
GR (1) GR3034035T3 (de)
IL (1) IL117157A (de)
MY (1) MY119366A (de)
PT (1) PT811058E (de)
UA (1) UA46005C2 (de)
WO (1) WO1996027003A1 (de)
ZA (1) ZA961450B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
JP4855074B2 (ja) * 2003-09-30 2012-01-18 一般財団法人化学及血清療法研究所 高純度血液凝固ｉｘ因子調製物およびその精製方法
KR100567448B1 (ko) * 2003-11-05 2006-04-04 주식회사 인투젠 형질전환 동물의 유즙 전처리방법 및 이를 통한 인체단백질의 정제방법
US7425539B2 (en) 2004-03-19 2008-09-16 Baxter International Inc. Factor IXa for the treatment of bleeding disorders
US10928366B2 (en) * 2007-01-26 2021-02-23 Sigma-Aldrich Co. Llc Compositions and methods for combining protein precipitation and solid phase extraction
US10434492B2 (en) * 2007-01-26 2019-10-08 Sigma-Aldrich Co. Llc Compositions and methods for solid phase extraction of lipids
AU2011234521B2 (en) * 2010-03-30 2015-04-23 Octapharma Ag A process for purifying Vitamin K dependent proteins such as coagulation factor IX
CN104560925B (zh) * 2014-12-30 2017-11-03 山东泰邦生物制品有限公司 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法
CN107540743A (zh) * 2017-10-11 2018-01-05 南岳生物制药有限公司 一种双层析法制备人纤维蛋白原的方法
CN111378029B (zh) * 2018-12-29 2023-05-05 四川远大蜀阳药业有限责任公司 一种人凝血因子ix的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
EP0317376B2 (de) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
CA2105282C (en) * 1991-03-01 2002-09-24 Centeon L.L.C. Preparation of factor ix
CN1064552C (zh) 1993-02-09 2001-04-18 奥克塔法马有限公司 失活无脂质被膜病毒的方法
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen

Also Published As

Publication number Publication date
ATE194167T1 (de) 2000-07-15
EA000222B1 (ru) 1998-12-24
CA2213577C (en) 2005-01-04
KR100436857B1 (ko) 2004-09-21
FI119377B (fi) 2008-10-31
WO1996027003A1 (en) 1996-09-06
JPH11500910A (ja) 1999-01-26
EP0811058A1 (de) 1997-12-10
UA46005C2 (uk) 2002-05-15
ES2147365T3 (es) 2000-09-01
IL117157A0 (en) 1996-06-18
CA2213577A1 (en) 1996-09-06
AU697217B2 (en) 1998-10-01
GR3034035T3 (en) 2000-11-30
EA199700196A1 (ru) 1998-02-26
EP0811058B1 (de) 2000-06-28
FI973469A0 (fi) 1997-08-22
AU4876196A (en) 1996-09-18
ZA961450B (en) 1996-08-27
DE69609054D1 (de) 2000-08-03
CN1181782A (zh) 1998-05-13
DE19506633A1 (de) 1996-08-29
US5919909A (en) 1999-07-06
FI973469L (fi) 1997-08-22
CN1105779C (zh) 2003-04-16
PT811058E (pt) 2000-10-31
DE69609054T2 (de) 2001-03-08
MY119366A (en) 2005-05-31
DK0811058T3 (da) 2000-10-16
KR19980702453A (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
IL138801A0 (en) Humanized antibody against human tissue factor and process for the preparation thereof
WO1990014067A3 (en) Methods for treating anxiety with sigma receptor ligands
FR2824568B1 (fr) Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
DK0766745T3 (da) Monoklonalt antistof, som er specifikt for humant 4-1BB samt cellelinje, som producerer dette
DE69433010D1 (de) Verfahren zur darstellung von oligonukleotiden
DE69424545D1 (de) Verfahren zur herstellung von immunoglobulin g konzentrat
DE69129302D1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
EE200000318A (et) Uudsed ühendid
GB9503601D0 (en) Method of treatment and method of manufacture of medicament
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
ZA961450B (en) A process for the preparation of factor ix from biological sources
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
ES2173879T3 (es) Procedimiento para la preparacion de conjugados a base de un participe especifico en la fijacion y de una proteina que contiene hidratos de carbono
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
ATE309371T1 (de) Protein mit dnase-aktivität
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
SE9404438D0 (sv) New process
DE69802171T8 (de) Verfahren zur Herstellung von 5,6-Dihydro-11H-dibenzo[a,d]cyclohept-11-enen
DE59603908D1 (de) Verfahren zur Herstellung von N',N'-disubstituierten 1,4-Diaminoanthrachinonen
DE59611353D1 (de) Transketolase-verwandtes protein
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
DE59610341D1 (de) Verfahren zur Herstellung von 2,4,6-Trichlorpyrimidin
ATE105570T1 (de) Modifizierte menschliche anti-rh(d)-antikoerper.

Legal Events

Date Code Title Description
FF Patent granted
HE Change of address of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees